190 related articles for article (PubMed ID: 19024097)
1. Long-term efficacy and safety of Chinese made sirolimus eluting stents: results, including off label usage, from two centres over three years.
Zhang Q; Xu B; Yang YJ; Qiao SB; Zhang RY; Zhang JS; Hu J; Qin XW; Chen JL; Shen WF; Gao RL
Chin Med J (Engl); 2008 Sep; 121(17):1670-4. PubMed ID: 19024097
[TBL] [Abstract][Full Text] [Related]
2. Sirolimus-eluting cobalt-chromium stents: two-year clinical results from first-in-man study on the Firebird 2 stent.
Xu B; Zhang Q; Yang YJ; Qiao SB; Zhang RY; Zhang JS; Hu J; Qin XW; Hong T; Li JP; Chen JL; Huo Y; Gao RL; Shen WF
Chin Med J (Engl); 2008 Mar; 121(6):492-7. PubMed ID: 18364131
[TBL] [Abstract][Full Text] [Related]
3. Firebird and cypher sirolimus-eluting stents and bare metal stents in treatment of very long coronary lesions.
Fan L; Chen LL; Lin CG; Peng YF; Zheng XC; Luo YK; Zhang FL; Chen JH; Yan XP; Huang ZR
Chin Med J (Engl); 2008 Aug; 121(16):1518-23. PubMed ID: 18982862
[TBL] [Abstract][Full Text] [Related]
4. Long-term clinical outcomes after bioabsorbable polymer- and durable polymer-based sirolimus-eluting stents implantation: two-year follow-up results from a large single-center database.
Liu HB; Xu B; Yang YJ; Wang Y; Qin XW; Yao M; Wu YJ; Yuan JQ; Chen J; You SJ; Dai J; Ma WH; Li JJ; Qiao SB; Chen JL; Li W; Gao RL
Chin Med J (Engl); 2009 Mar; 122(6):681-6. PubMed ID: 19323934
[TBL] [Abstract][Full Text] [Related]
5. A comparison of clinical and angiographic outcomes after Excel bioabsorbable polymer versus Firebird durable polymer rapamycin-eluting stent for the treatment of coronary artery disease in a "real world" setting: six-month follow-up results.
Liu HB; Xu B; Qiao SB; Yang YJ; Ma WH; Qin XW; Yao M; Wu YJ; Yuan JQ; Chen J; You SJ; Dai J; Xia R; Li JJ; Chen JL; Gao RL
Chin Med J (Engl); 2007 Apr; 120(7):574-7. PubMed ID: 17442205
[TBL] [Abstract][Full Text] [Related]
6. Outcomes of unselected recipients of sirolimus-eluting stents: the Cypher stent U.S. post-marketing surveillance registry.
Bezerra H; Perin E; Berger P; Block P; Ramee S; Katz S; Kellet M; Dippel E; Schaer G; Britto S; Cohen S; Costa M
J Invasive Cardiol; 2010 Feb; 22(2):48-55. PubMed ID: 20124586
[TBL] [Abstract][Full Text] [Related]
7. Comparison of long-term clinical outcome after successful implantation of Firebird sirolimus- and Taxus paclitaxel-eluting stents in Chinese population: analysis of a large single center registry.
Dou KF; Xu B; Yang YJ; Chen JL; Qiao SB; Wang Y; Li JJ; Qin XW; Yao M; Liu HB; Wu YJ; Chen J; Yuan JQ; You SJ; Li W; Gao RL
Chin Med J (Engl); 2010 Apr; 123(7):810-5. PubMed ID: 20497669
[TBL] [Abstract][Full Text] [Related]
8. Long-term clinical outcomes and stent thrombosis of sirolimus-eluting versus bare metal stents in patients with end-stage renal disease: results of Korean multicenter angioplasty team (KOMATE) Registry.
Kim BK; Oh S; Jeon DW; Yang JY; Kim JS; Park S; Choi D; Jang Y; Hong BK; Kwon HM; Lee SW; Goh CW; Kwon K; Ryu SK;
J Interv Cardiol; 2009 Oct; 22(5):411-9. PubMed ID: 19702679
[TBL] [Abstract][Full Text] [Related]
9. Firebird sirolimus eluting stent versus bare mental stent in patients with ST-segment elevation myocardial infarction.
Gao H; Yan HB; Zhu XL; Li N; Ai H; Wang J; Li SY; Yang D
Chin Med J (Engl); 2007 May; 120(10):863-7. PubMed ID: 17543174
[TBL] [Abstract][Full Text] [Related]
10. Sirolimus, Tacrolimus and Zotarolimus eluting stents to treat bifurcated lesions: a 7-month clinical outcome comparison.
Brugaletta S; Burzotta F; Trani C; Todaro D; Talarico G; Porto I; Leone AM; Niccoli G; Mazzari MA; Mongiardo R; Schiavoni G; Crea F
Minerva Cardioangiol; 2008 Feb; 56(1):35-42. PubMed ID: 18432167
[TBL] [Abstract][Full Text] [Related]
11. Long-term clinical outcomes with sirolimus-eluting coronary stents: five-year results of the RAVEL trial.
Morice MC; Serruys PW; Barragan P; Bode C; Van Es GA; Stoll HP; Snead D; Mauri L; Cutlip DE; Sousa E
J Am Coll Cardiol; 2007 Oct; 50(14):1299-304. PubMed ID: 17903626
[TBL] [Abstract][Full Text] [Related]
12. 5-year clinical outcomes after sirolimus-eluting stent implantation insights from a patient-level pooled analysis of 4 randomized trials comparing sirolimus-eluting stents with bare-metal stents.
Caixeta A; Leon MB; Lansky AJ; Nikolsky E; Aoki J; Moses JW; Schofer J; Morice MC; Schampaert E; Kirtane AJ; Popma JJ; Parise H; Fahy M; Mehran R
J Am Coll Cardiol; 2009 Sep; 54(10):894-902. PubMed ID: 19712798
[TBL] [Abstract][Full Text] [Related]
13. Safety and efficacy of the CYPHER Select Sirolimus-eluting stent in the "Real World"--clinical and angiographic results from the China CYPHER Select registry.
Gao RL; Xu B; Lu SZ; Chen JL; Han YL; Chen JZ; Gai LY; Ge JB; Wang WM; Du ZM; Huo Y; Wang LF; Gao W; Chen JY; He B; Jia GL; Yang ZJ; Cao KJ; Li WM; Shen WF; Wan Z; Huang DJ; Zhu GY;
Int J Cardiol; 2008 Apr; 125(3):339-46. PubMed ID: 17434617
[TBL] [Abstract][Full Text] [Related]
14. Two-year outcome of patients treated with sirolimus- versus paclitaxel-eluting stents in an unselected population with coronary artery disease (from the REWARDS Registry).
Roy P; Bonello L; de Labriolle A; Okabe T; Pinto Slottow TL; Steinberg DH; Torguson R; Smith K; Xue Z; Satler LF; Kent KM; Suddath WO; Pichard AD; Waksman R
Am J Cardiol; 2008 Aug; 102(3):292-7. PubMed ID: 18638589
[TBL] [Abstract][Full Text] [Related]
15. Incidence of thrombosis after implantation of drug-eluting stents in patients with coronary artery disease.
Chen JL; Yang YJ; Gao LJ; Huang JH; Qin XW; Qiao SB; Xu B; Yao M; Liu HB; Wu YJ; Yuan JQ; Chen J; You SJ; Dai J; Li JJ; Gao RL
Chin Med J (Engl); 2008 Nov; 121(21):2144-7. PubMed ID: 19080174
[TBL] [Abstract][Full Text] [Related]
16. Differential outcomes after sirolimus-eluting stent implantation: comparing on-label versus off-label patients in the 'real world'.
Jeremias A; Ruisi CP; Kirtane AJ; Lee T; Sylvia B; Pinto DS; Ho KK; Cutlip DE; Carrozza JP; Cohen DJ
Coron Artery Dis; 2008 Mar; 19(2):111-5. PubMed ID: 18300748
[TBL] [Abstract][Full Text] [Related]
17. Comparison of long-term clinical outcome after successful implantation of FIREBIRD and CYPHER sirolimus-eluting stents in daily clinical practice: analysis of a large single-center registry.
Xu B; Dou KF; Yang YJ; Chen JL; Qiao SB; Wang Y; Li JJ; Qin XW; Yao M; Liu HB; Wu YJ; Chen J; Yuan JQ; You SJ; Li W; Gao RL
Chin Med J (Engl); 2011 Apr; 124(7):990-6. PubMed ID: 21542955
[TBL] [Abstract][Full Text] [Related]
18. Long-term clinical benefit of sirolimus-eluting stents in patients with in-stent restenosis results of the RIBS-II (Restenosis Intra-stent: Balloon angioplasty vs. elective sirolimus-eluting Stenting) study.
Alfonso F; Pérez-Vizcayno MJ; Hernández R; Bethencourt A; Martí V; López-Mínguez JR; Angel J; Iñiguez A; Morís C; Cequier A; Sabaté M; Escaned J; Jiménez-Quevedo P; Bañuelos C; Suárez A; Macaya C;
J Am Coll Cardiol; 2008 Nov; 52(20):1621-7. PubMed ID: 18992651
[TBL] [Abstract][Full Text] [Related]
19. Safety of coronary sirolimus-eluting stents in daily clinical practice: one-year follow-up of the e-Cypher registry.
Urban P; Gershlick AH; Guagliumi G; Guyon P; Lotan C; Schofer J; Seth A; Sousa JE; Wijns W; Berge C; Deme M; Stoll HP;
Circulation; 2006 Mar; 113(11):1434-41. PubMed ID: 16534015
[TBL] [Abstract][Full Text] [Related]
20. Randomized comparison of everolimus-eluting and paclitaxel-eluting stents: two-year clinical follow-up from the Clinical Evaluation of the Xience V Everolimus Eluting Coronary Stent System in the Treatment of Patients with de novo Native Coronary Artery Lesions (SPIRIT) III trial.
Stone GW; Midei M; Newman W; Sanz M; Hermiller JB; Williams J; Farhat N; Caputo R; Xenopoulos N; Applegate R; Gordon P; White RM; Sudhir K; Cutlip DE; Petersen JL;
Circulation; 2009 Feb; 119(5):680-6. PubMed ID: 19171853
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]